Life-threatening Carboplatin Hypersensitivity During Conditioning for Autologous PBSC Transplantation: Successful Rechallenge After Desensitization
Overview
Affiliations
Carboplatin hypersensitivity has rarely been reported in patients receiving repeated cycles of therapy, but has not been reported in transplant settings. We report a case of carboplatin hypersensitivity during conditioning for autologous PBSC transplantation. The patient suddenly developed chest tightness, hemoptysis, hypoxia and hypotension, resulting in a transient myocardial ischemia. The pathophysiologic mechanism for the event seemed to be non-immune-mediated direct histamine release given the lack of prior exposure to platinum. Contrary to advice not to continue further treatment with carboplatin by some authors, we successfully desensitized the patient and subsequently gave more carboplatin as a part of conditioning. Awareness of carboplatin as one of the causes of hypersensitivity may help avoid further problems either by substitution or desensitization, along with premedications.
Venkatakrishnan J Indian J Ophthalmol. 2024; 72(8):1216-1218.
PMID: 39078969 PMC: 11451797. DOI: 10.4103/IJO.IJO_3309_23.
Safety and efficacy of an outpatient 12-step desensitization protocol for antineoplastic agents.
Eroglu I, Filippova O, Kirrane M, Orpen M, Almonte V, Thomas R Int J Gynecol Cancer. 2022; 32(8):1056-1062.
PMID: 35675969 PMC: 9924431. DOI: 10.1136/ijgc-2022-003466.
Narui C, Tanabe H, Shapiro J, Nagayoshi Y, Maruta T, Inoue M In Vivo. 2019; 33(6):2045-2050.
PMID: 31662536 PMC: 6899094. DOI: 10.21873/invivo.11702.
Hypersensitivity to Carboplatin in Children with Malignancy.
Ruggiero A, Rizzo D, Catalano M, Attina G, Riccardi R Front Pharmacol. 2017; 8:201.
PMID: 28446876 PMC: 5388748. DOI: 10.3389/fphar.2017.00201.
Clinical immunology review series: an approach to desensitization.
Krishna M, Huissoon A Clin Exp Immunol. 2010; 163(2):131-46.
PMID: 21175592 PMC: 3043304. DOI: 10.1111/j.1365-2249.2010.04296.x.